UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 306

Sortiert nach

Caffeine and Caffeic Acid Inhibit Growth and Modify Estrogen Receptor and Insulin-like Growth Factor I Receptor Levels in Human Breast Cancer

Clinical cancer research, 2015-04, Vol.21 (8), p.1877-1887

2015

Link zum Volltext

Verfügbarkeit prüfen

Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-Based Prospective Cohort

Clinical cancer research, 2015-08, Vol.21 (16), p.3640-3650

2015

Link zum Volltext

Verfügbarkeit prüfen

Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies

BMC cancer, 2011-08, Vol.11 (1), p.341-341, Article 341

2011

Link zum Volltext

Verfügbarkeit prüfen

Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases

Proceedings of the National Academy of Sciences - PNAS, 2011-08, Vol.108 (34), p.14252-14257

2011

Link zum Volltext

Verfügbarkeit prüfen

Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status

Cancer causes & control, 2013-05, Vol.24 (5), p.929-940

2013

Link zum Volltext

Verfügbarkeit prüfen

Interactions Between ABCB1 Genotype and Preoperative Statin Use Impact Clinical Outcomes Among Breast Cancer Patients

Frontiers in oncology, 2018-10, Vol.8, p.428-428

2018

Link zum Volltext

Verfügbarkeit prüfen

Coffee Consumption and CYP1A21F Genotype Modify Age at Breast Cancer Diagnosis and Estrogen Receptor Status

Cancer epidemiology, biomarkers & prevention, 2008-04, Vol.17 (4), p.895-901

2008

Link zum Volltext

Verfügbarkeit prüfen

Coffee Is Associated With Lower Breast Tumor Insulin-Like Growth Factor Receptor 1 Levels in Normal-Weight Patients and Improved Prognosis Following Tamoxifen or Radiotherapy Treatment

Frontiers in endocrinology (Lausanne), 2018-06, Vol.9 (JUN), p.306-306

2018

Link zum Volltext

Verfügbarkeit prüfen

Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients

BMC clinical pathology, 2015-05, Vol.15 (1), p.8-8, Article 8

2015

Link zum Volltext

Verfügbarkeit prüfen

Body Mass Index Influences the Prognostic Impact of Combined Nuclear Insulin Receptor and Estrogen Receptor Expression in Primary Breast Cancer

Frontiers in endocrinology (Lausanne), 2017-11, Vol.8 (NOV), p.332-332

2017

Link zum Volltext

Verfügbarkeit prüfen

Value of Epidermal Growth Factor Receptor, HER2, p53, and Steroid Receptors in Predicting the Efficacy of Tamoxifen in High-Risk Postmenopausal Breast Cancer Patients

Journal of clinical oncology, 2001-07, Vol.19 (14), p.3376-3384

2001

Link zum Volltext

Verfügbarkeit prüfen

The Prognostic Value of Angiogenesis by Chalkley Counting in a Confirmatory Study Design on 836 Breast Cancer Patients

Clinical cancer research, 2000-01, Vol.6 (1), p.139-146

2000

Link zum Volltext

Verfügbarkeit prüfen

Impacts of smoking on endocrine treatment response in a prospective breast cancer cohort

British journal of cancer, 2016-07, Vol.115 (3), p.382-390

2016

Link zum Volltext

Verfügbarkeit prüfen

Increasing preoperative body size in breast cancer patients between 2002 and 2016: implications for prognosis

Cancer causes & control, 2018-07, Vol.29 (7), p.643-656

2018

Link zum Volltext

Verfügbarkeit prüfen

Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease

EMBO molecular medicine, 2015-08, Vol.7 (8), p.1034-1047

2015

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic spectrum and time intervals in Sweden's first diagnostic center for patients with nonspecific symptoms of cancer

Acta oncologica, 2019-03, Vol.58 (3), p.296-305

2019

Link zum Volltext

Verfügbarkeit prüfen

Increasing protection after tamoxifen: insights from the extended adjuvant aromatase inhibitor trials

Journal of cancer research and clinical oncology, 2008-01, Vol.134 (1), p.7-17

Rose, Carsten

2008

Link zum Volltext

Verfügbarkeit prüfen

The prognostic impact of COX‐2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size

International journal of cancer, 2017-01, Vol.140 (1), p.163-175

2017

Link zum Volltext

Verfügbarkeit prüfen

“Good Old” clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers

European journal of cancer (1990), 2004-08, Vol.40 (12), p.1837-1841

2004

Link zum Volltext

Verfügbarkeit prüfen

CYP1A2--a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients

BMC cancer, 2016-03, Vol.16 (255), p.256-256, Article 256

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4218: Combined effect of COX2 genotype, ER status, body constitution, and treatment on risk of early events in breast cancer patients

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.4218-4218

2014

Link zum Volltext

Verfügbarkeit prüfen

High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy-Treated Patients-Results from a Population-Based Breast Cancer Cohort

Clinical cancer research, 2017-02, Vol.23 (3), p.766-777

2017

Link zum Volltext

Verfügbarkeit prüfen

IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort

BMC cancer, 2014-10, Vol.14 (1), p.759-759, Article 759

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract LB-194: AhR Arg554Lys impacts tumor ER expression and endocrine treatment response in breast cancer

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.LB-194-LB-194

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3805: Pre-diagnostic statin use among breast cancer patients - the relation to HMG-CoA reductase expression and disease-free survival

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.3805-3805

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 306

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(246)
Mit Volltextzugriff
(268)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Caffeine and Caffeic Acid Inhibit Growth and Modify Estrogen Receptor and Insulin-like Growth Factor I Receptor Levels in Human Breast Cancer

Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-Based Prospective Cohort

Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies

Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases

Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status

Interactions Between ABCB1 Genotype and Preoperative Statin Use Impact Clinical Outcomes Among Breast Cancer Patients

Coffee Consumption and CYP1A21F Genotype Modify Age at Breast Cancer Diagnosis and Estrogen Receptor Status

Coffee Is Associated With Lower Breast Tumor Insulin-Like Growth Factor Receptor 1 Levels in Normal-Weight Patients and Improved Prognosis Following Tamoxifen or Radiotherapy Treatment

Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients

Body Mass Index Influences the Prognostic Impact of Combined Nuclear Insulin Receptor and Estrogen Receptor Expression in Primary Breast Cancer

Value of Epidermal Growth Factor Receptor, HER2, p53, and Steroid Receptors in Predicting the Efficacy of Tamoxifen in High-Risk Postmenopausal Breast Cancer Patients

The Prognostic Value of Angiogenesis by Chalkley Counting in a Confirmatory Study Design on 836 Breast Cancer Patients

Impacts of smoking on endocrine treatment response in a prospective breast cancer cohort

Increasing preoperative body size in breast cancer patients between 2002 and 2016: implications for prognosis

Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease

Diagnostic spectrum and time intervals in Sweden's first diagnostic center for patients with nonspecific symptoms of cancer

Increasing protection after tamoxifen: insights from the extended adjuvant aromatase inhibitor trials

The prognostic impact of COX‐2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size

“Good Old” clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers

CYP1A2--a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients

Abstract 4218: Combined effect of COX2 genotype, ER status, body constitution, and treatment on risk of early events in breast cancer patients

High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy-Treated Patients-Results from a Population-Based Breast Cancer Cohort

IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort

Abstract LB-194: AhR Arg554Lys impacts tumor ER expression and endocrine treatment response in breast cancer

Abstract 3805: Pre-diagnostic statin use among breast cancer patients - the relation to HMG-CoA reductase expression and disease-free survival

Suchergebnisse filtern